col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


125 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Nature Immunology
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―19 Aged nasal epithelium is more prone to severe COVID-19 Ivan Zanoni
2 [GO] 2024―Apr―08 Immune dysregulation in long COVID Laura Ceglarek, Onur Boyman
3 [GO] 2024―Apr―08 Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease Felicity Liew, Claudia Efstathiou, Sara Fontanella, Matthew Richardson, Ruth Saunders, Dawid Swieboda, et al. (+1454)
4 [GO] 2024―Mar―14 Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination Valeria Fumagalli, Micol Ravà, Davide Marotta, Pietro Di Lucia, Elisa B. Bono, Leonardo Giustini, et al. (+19)
5 [GO] 2024―Mar―07 The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis Xin He, Xiantao Zhang, Bolin Wu, Jieyi Deng, Yongli Zhang, Airu Zhu, et al. (+32)
6 [GO] 2024―Mar―01 Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 Aimee L. Hanson, Matthew P. Mulè, Hélène Ruffieux, Federica Mescia, Laura Bergamaschi, Victoria S. Pelly, et al. (+10)
7 [GO] 2024―Mar―01 Alterations of iron homeostasis as a potential druggable driver of long COVID Oriana Marques, Martina U. Muckenthaler
8 [GO] 2024―Feb―20 A nasal vaccine elicits protective CD8+ T cell immunity against antigen shifted SARS-CoV-2 virus
9 [GO] 2024―Feb―15 Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection Baoling Ying, Tamarand L. Darling, Pritesh Desai, Chieh-Yu Liang, Igor P. Dmitriev, Nadia Soudani, et al. (+9)
10 [GO] 2024―Feb―09 Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection Baoling Ying, Tamarand L. Darling, Pritesh Desai, Chieh-Yu Liang, Igor P. Dmitriev, Nadia Soudani, et al. (+9)
11 [GO] 2024―Jan―11 Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 Kailin Yin, Michael J. Peluso, Xiaoyu Luo, Reuben Thomas, Min-Gyoung Shin, Jason Neidleman, et al. (+24)
12 [GO] 2024―Jan―02 Activation-based repertoire analysis for T cell clonal dynamics in hybrid COVID-19 immunity Louise C. Rowntree, Carolyn A. Cohen, Sophie A. Valkenburg
13 [GO] 2023―Dec―06 Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19 Emily S. Ford, Koshlan Mayer-Blackwell, Lichen Jing, Kerry J. Laing, Anton M. Sholukh, Russell St. Germain, et al. (+22)
14 [GO] 2023―Nov―02 SARS-CoV-2 exploits innate miscommunication for persistence Kewreshini Naidoo, Marcus Altfeld
15 [GO] 2023―Nov―02 SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells Nicolas Huot, Cyril Planchais, Pierre Rosenbaum, Vanessa Contreras, Beatrice Jacquelin, Caroline Petitdemange, et al. (+8)
16 [GO] 2023―Oct―23 Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19 Takato Kusakabe, Woan-Yu Lin, Jin-Gyu Cheong, Gagandeep Singh, Arjun Ravishankar, Stephen T. Yeung, et al. (+18)
17 [GO] 2023―Oct―23 Candida makes a lasting impression in COVID-19 Katherine Lagree, Peter Chen
18 [GO] 2023―Sep―21 Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2 Elie Antoun, Yanchun Peng, Tao Dong
19 [GO] 2023―Sep―21 Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection Mark M. Painter, Timothy S. Johnston, Kendall A. Lundgreen, Jefferson J. S. Santos, Juliana S. Qin, Rishi R. Goel, et al. (+54)
20 [GO] 2023―Sep―21 Multimodal single-cell datasets characterize antigen-specific CD8+ T cells across SARS-CoV-2 vaccination and infection Bingjie Zhang, Rabi Upadhyay, Yuhan Hao, Marie I. Samanovic, Ramin S. Herati, John D. Blair, et al. (+4)
21 [GO] 2023―Sep―18 Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Amy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, et al. (+27)
22 [GO] 2023―Sep―05 SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Amy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, et al. (+27)
23 [GO] 2023―Aug―21 Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2 Yves Zurbuchen, Jan Michler, Patrick Taeschler, Sarah Adamo, Carlo Cervia, Miro E. Raeber, et al. (+6)
24 [GO] 2023―Jul―24 New SARS-CoV-2 receptor Ioana Visan
25 [GO] 2023―Jul―17 Defining the role of natural killer cells in COVID-19 Madeline J. Lee, Catherine A. Blish
26 [GO] 2023―Jun―19 Two-birds-one-stone approach to combine protein and mRNA vaccines for COVID-19 George F. Gao
27 [GO] 2023―Jun―15 ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19 Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, Alane Izu, Jessica Shih-Lu Lee, Harry L. Bertera, et al. (+22)
28 [GO] 2023―May―29 Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities Wuji Zhang, Lukasz Kedzierski, Brendon Y. Chua, Mark Mayo, Claire Lonzi, Vanessa Rigas, et al. (+40)
29 [GO] 2023―May―29 Illuminating a blind spot in SARS-CoV-2 immunity Luis Graca, Ana Caetano Faria, Ruy M. Ribeiro
30 [GO] 2023―Apr―27 Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2 Yves Zurbuchen, Jan Michler, Patrick Taeschler, Sarah Adamo, Carlo Cervia, Miro E. Raeber, et al. (+6)
31 [GO] 2023―Apr―24 High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity Nicolás Gonzalo Nuñez, Jonas Schmid, Laura Power, Chiara Alberti, Sinduya Krishnarajah, Stefanie Kreutmair, et al. (+47)
32 [GO] 2023―Mar―15 The kinetics of chemokine autoantibodies in COVID-19 Furong Qi, Dapeng Li, Zheng Zhang
33 [GO] 2023―Mar―13 Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants Bin Ju, Qi Zhang, Ziyi Wang, Zhen Qin Aw, Peng Chen, Bing Zhou, et al. (+16)
34 [GO] 2023―Jan―30 The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19 Stefano Suzzi, Afroditi Tsitsou-Kampeli, Michal Schwartz
35 [GO] 2023―Jan―30 A patient-centric modeling framework captures recovery from SARS-CoV-2 infection Hélène Ruffieux, Aimee L. Hanson, Samantha Lodge, Nathan G. Lawler, Luke Whiley, Nicola Gray, et al. (+17)
36 [GO] 2023―Jan―30 Immunologic prediction of long COVID Randy Q. Cron
37 [GO] 2023―Jan―05 The COVID-19 immunology masterclass enters its third year Daniel M. Altmann
38 [GO] 2023―Jan―03 SARS-CoV-2 mucosal vaccine Stephanie Houston
39 [GO] 2022―Dec―19 Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children Qin Xu, Pedro Milanez-Almeida, Andrew J. Martins, Andrea J. Radtke, Kenneth B. Hoehn, Cihan Oguz, et al. (+38)
40 [GO] 2022―Dec―06 Impaired CD4+ T cell recognition of SARS-CoV-2 variants of concern
41 [GO] 2022―Dec―01 Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition Emily X. C. Tye, Elizabeth Jinks, Tracey A. Haigh, Baksho Kaul, Prashant Patel, Helen M. Parry, et al. (+7)
42 [GO] 2022―Sep―22 Memory CD8+ T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination Nadia Brasu, Ines Elia, Valentina Russo, Gaia Montacchiesi, Simona Aversano Stabile, Carlo De Intinis, et al. (+15)
43 [GO] 2022―Sep―06 SARS-CoV-2-cross-reactive T cells identified in pre-pandemic lower airway samples
44 [GO] 2022―Aug―29 Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2 Mariana O. Diniz, Elena Mitsi, Leo Swadling, Jamie Rylance, Marina Johnson, David Goldblatt, et al. (+2)
45 [GO] 2022―Aug―23 Ketogenesis and COVID-19 Stephanie Houston
46 [GO] 2022―Aug―23 Building effective collaborations for the study of COVID-19 across the severity spectrum Roseline S. Agyekum, Benjamin A. Abramoff, E. John Wherry, Nuala J. Meyer
47 [GO] 2022―Jun―27 The humoral response and antibodies against SARS-CoV-2 infection Hai Qi, Bo Liu, Xinquan Wang, Linqi Zhang
48 [GO] 2022―Jun―02 Catching the breadth of broadly protective antibodies to SARS-CoV-2 Kevin R. McCarthy
49 [GO] 2022―May―27 Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 Rosanna Asselta, Elvezia Maria Paraboschi, Matteo Stravalaci, Pietro Invernizzi, Paolo Bonfanti, Andrea Biondi, et al. (+25)
50 [GO] 2022―May―27 Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19 Michael Hultström, Robert Frithiof, Jonathan Grip, Linnea Lindelöf, Olav Rooijackers, Sara Pigazzini, et al. (+9)
51 [GO] 2022―Apr―21 T cells in COVID-19 - the kids are all right John D. Altman
52 [GO] 2022―Apr―05 SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells Anastasia A. Minervina, Mikhail V. Pogorelyy, Allison M. Kirk, Jeremy Chase Crawford, E. Kaitlynn Allen, Ching-Heng Chou, et al. (+46)
53 [GO] 2022―Mar―21 Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, Hyon-Xhi Tan, Thakshila Amarasena, Arnold Reynaldi, et al. (+9)
54 [GO] 2022―Mar―17 STINGing type I IFN-mediated immunopathology in COVID-19 Evangelos Andreakos
55 [GO] 2022―Feb―28 An engineered bispecific human monoclonal antibody against SARS-CoV-2 Zhaohui Li, Shihua Li, Gen Zhang, Weiyu Peng, Zhen Chang, Xue Zhang, et al. (+19)
56 [GO] 2022―Feb―24 Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses Jeffrey A. Tomalka, Mehul S. Suthar, Steven G. Deeks, Rafick Pierre Sekaly
57 [GO] 2022―Feb―22 SARS-CoV-2 learned the ‘Alpha’bet of immune evasion GuanQun Liu, Michaela U. Gack
58 [GO] 2022―Feb―03 Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses Victoria G. Hall, Victor H. Ferreira, Heidi Wood, Matthew Ierullo, Beata Majchrzak-Kita, Kathy Manguiat, et al. (+4)
59 [GO] 2022―Feb―01 Innate immunity: the first line of defense against SARS-CoV-2 Michael S. Diamond, Thirumala-Devi Kanneganti
60 [GO] 2022―Feb―01 The T cell immune response against SARS-CoV-2 Paul Moss
61 [GO] 2022―Feb―01 Immunology of SARS-CoV-2 infection in children Janet Chou, Paul G. Thomas, Adrienne G. Randolph
62 [GO] 2022―Jan―31 Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules Matteo Stravalaci, Isabel Pagani, Elvezia Maria Paraboschi, Mattia Pedotti, Andrea Doni, Francesco Scavello, et al. (+23)
63 [GO] 2022―Jan―24 COVID-19 vaccine trials must include helminth-infected cohorts Thomas G. Egwang, Tonny Jimmy Owalla, Margaret Kemigisha
64 [GO] 2022―Jan―13 Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection Chansavath Phetsouphanh, David R. Darley, Daniel B. Wilson, Annett Howe, C. Mee Ling Munier, Sheila K. Patel, et al. (+6)
65 [GO] 2021―Dec―22 Boosted immunity to the common cold might protect children from COVID-19 Jason J. Lavinder, Gregory C. Ippolito
66 [GO] 2021―Dec―22 Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19 Anna H. E. Roukens, Cilia R. Pothast, Marion König, Wesley Huisman, Tim Dalebout, Tamar Tak, et al. (+91)
67 [GO] 2021―Dec―22 Cross-reactive adaptive immunity against coronaviruses in young children
68 [GO] 2021―Dec―22 Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection Alexander C. Dowell, Megan S. Butler, Elizabeth Jinks, Gokhan Tut, Tara Lancaster, Panagiota Sylla, et al. (+38)
69 [GO] 2021―Dec―20 Role of the T cell vitamin D receptor in severe COVID-19 Jay K. Kolls, Robert F. Garry
70 [GO] 2021―Dec―01 An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease Yanchun Peng, Suet Ling Felce, Danning Dong, Frank Penkava, Alexander J. Mentzer, Xuan Yao, et al. (+60)
71 [GO] 2021―Nov―30 BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2 R. Camille Brewer, Nitya S. Ramadoss, Lauren J. Lahey, Shaghayegh Jahanbani, William H. Robinson, Tobias V. Lanz
72 [GO] 2021―Nov―24 Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection Evangelos Andreakos, Laurent Abel, Donald C. Vinh, Elżbieta Kaja, Beth A. Drolet, Qian Zhang, et al. (+47)
73 [GO] 2021―Nov―15 Maternal COVID-19 leaves a lasting immunological impression on the fetus Brahm Coler, Kristina Adams Waldorf
74 [GO] 2021―Oct―29 Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations Vincent Dussupt, Rajeshwer S. Sankhala, Letzibeth Mendez-Rivera, Samantha M. Townsley, Fabian Schmidt, Lindsay Wieczorek, et al. (+40)
75 [GO] 2021―Oct―22 ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection Xuetao Cao
76 [GO] 2021―Oct―21 Microbiota and compartment matter in the COVID-19 response Simon P. Jochems, Daniela M. Ferreira, Hermelijn H. Smits
77 [GO] 2021―Oct―19 Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection Deeksha Munnur, Qiwen Teo, Denzel Eggermont, Horace H. Y. Lee, Fabien Thery, Julian Ho, et al. (+11)
78 [GO] 2021―Oct―19 A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection Evangelos Andreakos, Laurent Abel, Donald C. Vinh, Elżbieta Kaja, Beth A. Drolet, Qian Zhang, et al. (+47)
79 [GO] 2021―Oct―08 The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate Sarah Gee, Manju Chandiramani, Jeffrey Seow, Emily Pollock, Carlotta Modestini, Abhishek Das, et al. (+4)
80 [GO] 2021―Oct―05 SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19 Supriya Ravichandran, Juanjie Tang, Gabrielle Grubbs, Youri Lee, Sara Pourhashemi, Laila Hussaini, et al. (+7)
81 [GO] 2021―Sep―23 Anecdotes from the pandemic
82 [GO] 2021―Sep―23 The embers underneath the CoV-2 pandemic: a semblance of the persistent burn of health inequities and disparities in the United States Harlan P. Jones, Nicole R. Phillips
83 [GO] 2021―Sep―01 Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection Nikaïa Smith, Pedro Goncalves, Bruno Charbit, Ludivine Grzelak, Maxime Beretta, Cyril Planchais, et al. (+15)
84 [GO] 2021―Aug―20 mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, Matthew Gagne, Lilin Lai, Juan I. Moliva, et al. (+49)
85 [GO] 2021―Aug―13 Author Correction: The COVID-19 response in the United Arab Emirates: challenges and opportunities Ahmed R. Alsuwaidi, Farida I. Al Hosani, Gehad ElGhazali’s, Basel K. al-Ramadi
86 [GO] 2021―Jul―27 The COVID-19 response in the United Arab Emirates: challenges and opportunities Ahmed R. Alsuwaidi, Farida I. Al Hosani, Gehad ElGhazli, Basel K. al-Ramadi
87 [GO] 2021―Jul―27 Long COVID Ioana Visan
88 [GO] 2021―Jun―28 A STING in the tail for SARS-CoV-2 Nicholas J. Bernard
89 [GO] 2021―Jun―21 SARS-CoV-2-specific hotspots in virus-host interaction networks Herbert B. Schiller, Merlijn van Breugel, Martijn C. Nawijn
90 [GO] 2021―Jun―08 SARS-CoV-2 takes its Toll Alan Sariol, Stanley Perlman
91 [GO] 2021―May―26 Cellular disturbances in COVID-19 Laurie A. Dempsey
92 [GO] 2021―May―25 The accelerating COVID-19 epidemic in Sudan Maowia M. Mukhtar, Mustafa Khogali
93 [GO] 2021―May―20 Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection Jianmin Zuo, Alexander C. Dowell, Hayden Pearce, Kriti Verma, Heather M. Long, Jusnara Begum, et al. (+18)
94 [GO] 2021―May―07 TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines Min Zheng, Rajendra Karki, Evan Peter Williams, Dong Yang, Elizabeth Fitzpatrick, Peter Vogel, et al. (+2)
95 [GO] 2021―Apr―19 Immunity after SARS-CoV-2 infections Prasanna Jagannathan, Taia T. Wang
96 [GO] 2021―Apr―13 COVID-19 research and science in the service of public health: the example of Greece Sotirios Tsiodras
97 [GO] 2021―Mar―26 Taiwan’s experience in fighting COVID-19 Shih-Chung Chen
98 [GO] 2021―Mar―15 Lessons learned: new insights on the role of cytokines in COVID-19 Maja Buszko, Aleksandra Nita-Lazar, Jung-Hyun Park, Pamela L. Schwartzberg, Daniela Verthelyi, Howard A. Young, Amy S. Rosenberg
99 [GO] 2021―Mar―05 Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection Jianmin Zuo, Alexander C. Dowell, Hayden Pearce, Kriti Verma, Heather M. Long, Jusnara Begum, et al. (+14)
100 [GO] 2021―Feb―24 India’s crusade against COVID-19 Manisha Madkaikar, Nivedita Gupta, Reetika Malik Yadav, Umair Ahmed Bargir
101 [GO] 2021―Feb―24 COVID-19 control in Vietnam Le Van Tan
102 [GO] 2021―Feb―24 From denial to hope: Brazil deals with a prolonged COVID-19 epidemic course Marcela F. Lopes
103 [GO] 2021―Feb―24 Facing up to the COVID-19 pandemic in Argentina Gabriel A. Rabinovich, Jorge Geffner
104 [GO] 2021―Feb―24 New Zealand’s science-led response to the SARS-CoV-2 pandemic Jemma L. Geoghegan, Nicole J. Moreland, Graham Le Gros, James E. Ussher
105 [GO] 2021―Feb―24 Living the SARS-CoV-2 pandemic in Turkey Deniz Çağdaş
106 [GO] 2021―Feb―02 Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity Héloïse Flament, Matthieu Rouland, Lucie Beaudoin, Amine Toubal, Léo Bertrand, Samuel Lebourgeois, et al. (+29)
107 [GO] 2020―Dec―17 SARS-CoV-2 neuroinvasion Laurie A. Dempsey
108 [GO] 2020―Dec―04 Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison Ioanna-Evdokia Galani, Nikoletta Rovina, Vicky Lampropoulou, Vasiliki Triantafyllia, Maria Manioudaki, Eleftherios Pavlos, et al. (+10)
109 [GO] 2020―Nov―26 Deciphering the ins and outs of SARS-CoV-2-specific T cells André Perez-Potti, Joshua Lange, Marcus Buggert
110 [GO] 2020―Nov―24 Establishment of an African green monkey model for COVID-19 and protection against re-infection Courtney Woolsey, Viktoriya Borisevich, Abhishek N. Prasad, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, et al. (+9)
111 [GO] 2020―Nov―18 Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 Enrico Brunetta, Marco Folci, Barbara Bottazzi, Maria De Santis, Giuseppe Gritti, Alessandro Protti, et al. (+23)
112 [GO] 2020―Nov―09 Proinflammatory IgG Fc structures in patients with severe COVID-19 Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, Vamsee Mallajosyula, Anthony S. Buzzanco, Robert Sherwood, et al. (+21)
113 [GO] 2020―Nov―05 Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, Matthew R. Baldwin, Wen-Hsuan Lin, Sandeep Wontakal, et al. (+25)
114 [GO] 2020―Nov―02 Overlapping B cell pathways in severe COVID-19 and lupus A. Darise Farris, Joel M. Guthridge
115 [GO] 2020―Oct―07 Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 Matthew C. Woodruff, Richard P. Ramonell, Doan C. Nguyen, Kevin S. Cashman, Ankur Singh Saini, Natalie S. Haddad, et al. (+27)
116 [GO] 2020―Sep―30 SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition Annika Nelde, Tatjana Bilich, Jonas S. Heitmann, Yacine Maringer, Helmut R. Salih, Malte Roerden, et al. (+36)
117 [GO] 2020―Sep―07 T cells in COVID-19 - united in diversity Leo Swadling, Mala K. Maini
118 [GO] 2020―Sep―04 Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Yanchun Peng, Alexander J. Mentzer, Guihai Liu, Xuan Yao, Zixi Yin, Danning Dong, et al. (+58)
119 [GO] 2020―Sep―02 Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function Emma S. Winkler, Adam L. Bailey, Natasha M. Kafai, Sharmila Nair, Broc T. McCune, Jinsheng Yu, et al. (+11)
120 [GO] 2020―Aug―27 The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge Maja Buszko, Jung-Hyun Park, Daniela Verthelyi, Ranjan Sen, Howard A. Young, Amy S. Rosenberg
121 [GO] 2020―Aug―27 Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection Asmaa Hachim, Niloufar Kavian, Carolyn A. Cohen, Alex W. H. Chin, Daniel K. W. Chu, Chris K. P. Mok, et al. (+6)
122 [GO] 2020―Aug―24 SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function Emma S. Winkler, Adam L. Bailey, Natasha M. Kafai, Sharmila Nair, Broc T. McCune, Jinsheng Yu, et al. (+11)
123 [GO] 2020―Aug―17 ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection Asmaa Hachim, Niloufar Kavian, Carolyn A. Cohen, Alex W. H. Chin, Daniel K. W. Chu, Chris K. P. Mok, et al. (+6)
124 [GO] 2020―Aug―12 Single-cell landscape of immunological responses in patients with COVID-19 Ji-Yuan Zhang, Xiang-Ming Wang, Xudong Xing, Zhe Xu, Chao Zhang, Jin-Wen Song, et al. (+15)
125 [GO] 2020―Jul―01 Drama out of a crisis: the cultural sector responds to healthcare professionals impacted by COVID-19 Alex Mermikides
 [1] 

125 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.016 sec